2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Paranasal Sinus Cancer
Paranasal sinus cancer, though rare, presents significant challenges in both diagnosis and treatment. These cancers originate in the nasal cavity and sinuses, often diagnosed at an advanced stage due to their subtle symptoms like congestion or facial pain. Research in this area focuses on improving early detection methods, such as imaging techniques and biomarker identification, to enable timely interventions.
Furthermore, advancements in treatment modalities like surgery, radiation therapy, and chemotherapy aim to enhance outcomes and preserve quality of life for patients. Immunotherapy and targeted therapies also hold promise in addressing specific genetic mutations driving these cancers. Collaborative efforts between oncologists, surgeons, and researchers are vital in unraveling the complexities of paranasal sinus cancer and devising more effective strategies to combat it.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China